183 related articles for article (PubMed ID: 36700469)
1. A high level of the long non-coding RNA
She Q; Chen Y; Liu H; Tan J; Li Y
Bioengineered; 2022 May; 13(5):13437-13451. PubMed ID: 36700469
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA MCF2L-AS1 promotes the aggressiveness of colorectal cancer by sponging miR-874-3p and thereby up-regulating CCNE1.
Huang FK; Zheng CY; Huang LK; Lin CQ; Zhou JF; Wang JX
J Gene Med; 2021 Jan; 23(1):e3285. PubMed ID: 33037865
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p/FOXM1 signaling axis.
Zhang Z; Yang W; Li N; Chen X; Ma F; Yang J; Zhang Y; Chai X; Zhang B; Hou X; Luo S; Hua Y
Carcinogenesis; 2021 Feb; 42(2):263-271. PubMed ID: 32860508
[TBL] [Abstract][Full Text] [Related]
4. The lncRNA MCF2L-AS1 controls osteogenic differentiation by regulating miR-33a.
Chen Q; Wang M; Wu S
Cell Cycle; 2020 May; 19(9):1059-1065. PubMed ID: 32255731
[TBL] [Abstract][Full Text] [Related]
5. SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1/IGF2/MEK/ERK axis.
Zhu Y; Yang L; Wang J; Li Y; Chen Y
J Gynecol Oncol; 2022 Nov; 33(6):e75. PubMed ID: 36245227
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MCF2L-AS1 aggravates the malignant development of colorectal cancer via targeting miR-105-5p/RAB22A axis.
Kong W; Li H; Xie L; Cui G; Gu W; Zhang H; Ma W; Zhou Y
BMC Cancer; 2021 Sep; 21(1):1069. PubMed ID: 34592939
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.
Bao G; Huang J; Pan W; Li X; Zhou T
Cancer Med; 2020 Jan; 9(1):278-289. PubMed ID: 31701672
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA MCF2L-AS1 promotes the cancer stem cell-like traits in non-small cell lung cancer cells through regulating miR-873-5p level.
Li S; Lin L
Environ Toxicol; 2021 Jul; 36(7):1457-1465. PubMed ID: 33783940
[TBL] [Abstract][Full Text] [Related]
9. E2F1-induced long non-coding RNA MCF2L-AS1 modulates Cyclin D1 mRNA stability through ELAVL1 to induce Gefitinib resistance in non-small cell lung cancer.
Shan KZ; Yang SF; Deng YJ; Yue PY; Du ZQ
Acta Biochim Pol; 2022 Oct; 69(4):795-804. PubMed ID: 36257058
[TBL] [Abstract][Full Text] [Related]
10. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
[TBL] [Abstract][Full Text] [Related]
11. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
Ma D; Chen C; Wu J; Wang H; Wu D
Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of long noncoding RNA B4GALT1-AS1 is associated with breast cancer development.
Ahvaz S; Amini M; Yari A; Baradaran B; Jebelli A; Mokhtarzadeh A
Sci Rep; 2024 Feb; 14(1):3114. PubMed ID: 38326326
[TBL] [Abstract][Full Text] [Related]
13. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MIF-AS1 promotes breast cancer cell proliferation, migration and EMT process through regulating miR-1249-3p/HOXB8 axis.
Ding J; Wu W; Yang J; Wu M
Pathol Res Pract; 2019 Jul; 215(7):152376. PubMed ID: 31097355
[TBL] [Abstract][Full Text] [Related]
15. LncRNA ZFPM2-AS1 aggravates the malignant development of breast cancer via upregulating JMJD6.
Zhao YF; Li L; Li HJ; Yang FR; Liu ZK; Hu XW; Wang Q
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11139-11147. PubMed ID: 33215431
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA TTN-AS1 promotes the metastasis in breast cancer by epigenetically activating DGCR8.
Qiu P; Dou Y; Ma LZ; Tang XX; Liu XL; Chen JW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10835-10841. PubMed ID: 31858552
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2.
Zhou B; Guo H; Tang J
Med Sci Monit; 2019 Feb; 25():1242-1253. PubMed ID: 30768589
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ARAP1-AS1 accelerates cell proliferation and migration in breast cancer through miR-2110/HDAC2/PLIN1 axis.
Lu C; Wang X; Zhao X; Xin Y; Liu C
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32110804
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
[TBL] [Abstract][Full Text] [Related]
20. lncRNA
Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
